{"paper_id":"f83c3115-668a-4b04-96e3-d9df1380c259","body_text":"Abstract\nAcute pelvic pain may constitute a medical or surgical emergency. This chapter reviews the differential diagnosis for acute pelvic pain, including postoperative complications, infections, pelvic masses, functional causes of pain (such as dysmenorrhea and adenomyosis), pregnancy-related issues, and nongynecologic etiologies. Diagnosis and management, including emergent resuscitation, are reviewed, subdivided by infectious and noninfectious etiologies of pain.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nJung PJ, Merrell RC. Acute abdomen. Gastroenterol Clin North Am. 1988;17:227–44.\nVincent JL, De Backer D. Circulatory shock. N Engl J Med. 2014;370:583.\nRose DK, Cohen MM, DeBoer DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology. 1996;84:772–81.\nGutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care. 2004;8:373–81.\nCommittee on Trauma. Advanced trauma life support 1 student manual. 8th ed. Chicago: American College of Surgeons; 2008.\nFischerova D. Urgent care in gynaecology: resuscitation and management of sepsis and acute blood. Best Pract Res Clin Obstet Gynaecol. 2009;23:679–90.\nDellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.\nDescloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, et al. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008;27:37–43.\nHo CS, Bhatnagar J, Cohen AL, Hacker JK, Zane SB, Reagan S, et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol. 2009;201:459.e1–7.\nNair M, Alabi C, Hirsch PI. Toxic shock syndrome: a silent killer. J Obstet Gynaecol. 2006;26:825.\nNezhat C, Farhady P, Lemyre M. Septic pelvic thrombophlebitis following laparoscopic hysterectomy. JSLS. 2009;13:84–6.\nWiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis. 2005;32:400–5.\nMitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013;27:793–809.\nJossens MO, Eskenazi B, Schachter J, Sweet RL, et al. Risk factors for pelvic inflammatory disease. A case control study. Sex Transm Dis. 1996;23:239–47.\nPelvic inflammatory disease. Centers for Disease Control and Prevention website. http://www.cdc.gov/std/tg2015/pid.htm. Updated 4 June 2015. Accessed 7 July 2015.\nLareau SM, Beigi RH. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am. 2008;22:693–708.\nSasaki KJ, Miller CE. Adnexal torsion: review of the literature. J Minim Invasive Gynecol. 2014;21:196–202.\nAmerican College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of adnexal masses. Obstet Gynecol. 2007;110:201–14.\nStewart EA. Uterine fibroids. Lancet. 2001;357:293–8.\nMurase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis and treatment. Radiology. 1999;19:1179–97.\nCaglar GS, Tasci Y, Kayikcioglu F. Management of prolapsed pedunculated myomas. Int J Gynaecol Obstet. 2005;89:146–7.\nWallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393–406.\nGupta S, Manyonda IT. Acute complications of fibroids. Best Pract Res Clin Obstet Gynaecol. 2009;23:609–17.\nLaughlin SK, Stewart EA. Uterine leiomyomas: individualizing the approach to a heterogeneous condition. Obstet Gynecol. 2011;117:396–403.\nMcLucas B. Diagnosis, imaging and anatomical classification of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:627–42.\nBraaten KP, Benson CB, Maurer R, Goldberg AB. Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies. Obstet Gynecol. 2011;118:1014–20.\nBraaten KP, Goldberg AB. Malpositioned IUDs: when you should intervene (and when you should not). OBG Manage. 2012;24:38–46.\nMoschos E, Twickler DM. Intrauterine devices in early pregnancy: findings on ultrasound and clinical outcomes. Am J Obstet Gynecol. 2011;204:427.e1–6.\nPakarinen P, Luukkainen T. Five years’ experience with a small intracervical/intrauterine levonorgestrel-releasing device. Contraception. 2005;72:342–5.\nWorld Health Organization, Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use. 2nd ed. Geneva: World Health Organization; 2004. http://whqlibdoc.who.int/publications/2004/9241562846.pdf?ua=1. Accessed 22 July 2015.\nCenters for Disease Control and Prevention (CDC). U S. Medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep. 2010;59:1–86.\nOsayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Physician. 2014;89:341–6.\nDawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428–41.\nMarjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010;(1):CD001751.\nDavis AR, Westhoff C, O’Connell K, Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol. 2005;106:97–104.\nMarinho AO, Sallam HN, Goessens L, Collins WP, Campbell S. Ovulation side and occurrence of mittelschmerz in spontaneous and induced ovarian cycles. Br Med J (Clin Res Ed). 1982;284:632.\nBottomley C, Bourne T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol. 2009;23:711–24.\nSolnik MJ, Munro MG. Indications and alternatives to hysterectomy. Clin Obstet Gynecol. 2014;57:14–42.\nGiudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362:2389–98.\nPractice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101:927–35.\nSaba L, Sulcis R, Melis GB, de Cecco CN, Laghi A, Piga M, et al. Endometriosis: the role of magnetic resonance imaging. Acta Radiol. 2015;56:355–67.\nBromley B, Shipp TD, Benacerraf B. Adenomyosis: sonographic findings and diagnostic accuracy. J Ultrasound Med. 2000;19:529–34.\nAmirbekian S, Hooley RJ. Ultrasound evaluation of pelvic pain. Radiol Clin North Am. 2014;52:1215–35.\nDueholm M, Lundorf E, Hansen ES, Sørensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for diagnosis of adenomyosis. Fertil Steril. 2001;76:588–94.\nCicchiello LA, Hamper UM, Scoutt LM. Ultrasound evaluation of gynecologic causes of pelvic pain. Obstet Gynecol Clin North Am. 2011;38:85–114.\nDueholm M, Lundorf E. Transvaginal ultrasound or MRI for diagnosis of adenomyosis. Curr Opin Obstet Gynecol. 2007;19:505–12.\nBragheto AM, Caserta N, Bahamondes L, Petta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007;76:195–9.\nDietrich JE. An update on adenomyosis in the adolescent. Curr Opin Obstet Gynecol. 2010;22:388–92.\nLapinsky SE. Obstetric infections. Crit Care Clin. 2013;29:509–20.\nPractice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188–93.\nKamer SM, Foley KF, Schmidt RL, Greene DN. Analytical sensitivity of four commonly used hCG point of care devices. Clin Biochem. 2015;48:448–52.\nScalea TM, Rodriguez A, Chiu WC, Brenneman FD, Fallon Jr WF, Kato K, et al. Focused Assessment with Sonography for Trauma (FAST): results from an international consensus conference. J Trauma. 1999;46:466–72.\nErber WN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol. 2006;19:97–112.\nLevy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg. 2012;114:261–74.\nBartlett J. Sepsis – syndromes. In: Pham P, Auwaerter P, Bartlett J, Johns Hopkins M, editors. Johns Hopkins ABX guide: diagnosis and treatment of infectious diseases [e-book]. Burlington: Jones and Bartlett Learning; 2012. Available from: eBook Collection (EBSCOhost), Ipswich. Accessed 8 June 2015.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nCopyright information\n© 2016 Springer International Publishing Switzerland\nAbout this chapter\nCite this chapter\nBrady, P.C., Carusi, D. (2016). Acute Pelvic Pain. In: Handbook of Consult and Inpatient Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-27724-0_1\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-27724-0_1\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-27722-6\nOnline ISBN: 978-3-319-27724-0\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}